
Sign up to save your podcasts
Or


A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.
By Rahul Banerjee, MD4.8
2727 ratings
A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.

137 Listeners

317 Listeners

498 Listeners

73 Listeners

120 Listeners

28 Listeners

1,145 Listeners

187 Listeners

22 Listeners

367 Listeners

52 Listeners

137 Listeners

51 Listeners

192 Listeners

31 Listeners